Related Experiment Videos
Systemic-Pulmonary shunts inneonates and infants using microporous expanded polytetrafluoroethylene: immediate and
Insights
Microporous polytetrafluoroethylene (PTFE) grafts effectively relieve cyanosis in infants with congenital heart disease. This reliable shunt offers excellent long-term patency, proving superior to other methods for neonates.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomaterials Science
Background:
- Cyanotic congenital heart disease presents significant challenges in neonates and infants.
- Systemic-pulmonary artery shunts are crucial palliative procedures.
- Traditional shunt materials and techniques have limitations.
Purpose of the Study:
- To evaluate the efficacy and safety of microporous polytetrafluoroethylene (PTFE) grafts for systemic-pulmonary artery shunts in infants.
- To compare PTFE shunt outcomes with existing surgical options.
Main Methods:
- Retrospective analysis of 30 infants undergoing PTFE shunt placement between 1976 and 1979.
- Focus on neonates (average age 5.3 days) and infants with cyanotic heart disease.
- Follow-up data collected up to 3.5 years post-procedure.
Main Results:
- No operative deaths; 5 hospital deaths (2 shunt-related).
- Cyanosis relief achieved in all patients.
- Excellent long-term patency observed; 3 patients experienced mild congestive heart failure responsive to digitalis.
Conclusions:
- Microporous PTFE grafts demonstrate reliability and excellent late patency for systemic-pulmonary artery shunts.
- PTFE shunts are considered superior to central or Potts shunts for neonates and infants.
- PTFE grafts offer comparable reliability to Blalock-Taussig shunts.
Abstract:
Thirty infants with various types of cyanotic congenitl heart disease underwent systemic-pulmonary artery shunts with a microporous polytetrafluoroethylene (PTFE) graft between May, 1976, and July, 1979. Sixteen of them were less than 1 month old, and the average age of the neonates was 5.3 days. There were no operative deaths and 5 hospital deaths, 2 related directly to the shunt. Five patients required early revision of the shunt. Relief from cyanosis was achieved in each patient. Twenty-five patients have been followed up to three and one-half years. There have been 2 late deaths and one late occlusion of the shunt. One patient outgrew the shunt and required secondary shunting procedures. Three of 30 patients have evidenced mild congestive heart failure, which has responded to digitalis. Because of the reliability and excellent late patency of the PTFE prosthesis, we consider it to be superior to a central or Potts shunt for relief from cyanosis in the neonate and infant, and as reliable as a Blalock-Taussig shunt.